# Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops

> **NCT05660681** · NA · COMPLETED · sponsor: **Calm Water Therapeutics LLC** · enrollment: 34 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** glycerin 0.7%/PEG 400 0.3%
- **DRUG:** polyethylene glycol 400 0.4%/propylene glycol 0.3%

## Key facts

- **NCT ID:** NCT05660681
- **Lead sponsor:** Calm Water Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-12
- **Primary completion:** 2023-08-15
- **Final completion:** 2023-08-15
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2023-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05660681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05660681, "Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05660681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*